Contravisory Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-133
| Closed | -$15.3K | – | 418 |
|
|
2024
Q3 | $15.3K | Buy |
133
+16
| +14% | +$1.84K | ﹤0.01% | 302 |
|
|
2024
Q2 | $16.1K | Buy |
+117
| New | +$16.1K | ﹤0.01% | 293 |
|
|
2020
Q4 | – | Sell |
-1,273
| Closed | -$122K | – | 270 |
|
|
2020
Q3 | $122K | Hold |
1,273
| – | – | 0.04% | 179 |
|
|
2020
Q2 | $151K | Buy |
+1,273
| New | +$151K | 0.06% | 169 |
|